Skip to main content
. Author manuscript; available in PMC: 2019 Jan 4.
Published in final edited form as: Transl Cancer Res. 2017 May;6(Suppl 3):S578–S584. doi: 10.21037/tcr.2017.05.05

Table 1.

Comparison of the two BCAT isoenzymes

Variables BCAT1 BCAT2
Other names BCATc (cytosolic) BCATm (mitochondrial)
Tissue distribution Brain, gonads, activated CD4+ T-cells (25) Most tissues, excluding liver (43,44); high in exocrine pancreas (44)
Knockout phenotypes Activated Bcat1−/− murine T-cells exhibit elevated mTORC1 signaling and glycolytic metabolism (25); bcat-1 null C. elegans have an extended lifespan and healthspan (45) Bcat2−/− mice have high circulating BCAAs, improved insulin sensitivity and glucose tolerance, and elevated energy expenditure (46); Bcat2−/− mice have lower exercise capacity (47); required in subset of PDAC (24)
Expression in cancer cells Over-expressed in: glioblastoma (48); nasopharyngeal carcinoma (39); cancers with elevated MYC? (39) Over-expressed in: PDAC (KP−/−C model) (16); cancers with active SREBP1 and low AMPK activity? (24)

BCAT, branched chain amino acid transferase; PDAC, pancreatic ductal adenocarcinoma.